Skip to main content
    T

    Tilray Inc (TLRY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $2.35
    +0.01 (+0.43%)

    Market Cap: $345.82M

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Tilray Inc (TLRY) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Tilray (TLRY) has a market cap of $345.82M and an enterprise value of $332.28M. Its share count is up 25.76% from a year earlier. It kept -17.05% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 3.92% below the market cap, as cash exceeds debt.

    Market Cap$345.82M
    Enterprise Value$332.28M
    Latest price (Nov 17, 2026)$2.35

    Key Dates

    The next earnings report is expected on Jan 6, 2027, covering the quarter ending Nov 30, 2026.

    Next Earnings DateJan 6, 2027 (expected)
    Last Earnings DateOct 8, 2026
    Fiscal Year EndMay

    Share Statistics

    The share count rose 19.23% in the quarter ended Aug 31, 2026 and grew 23.41% a year over 2 years.

    Shares Outstanding133.34M
    Shares Change (YoY)+25.76%
    Shares Change (QoQ)+19.23%
    Share Count Growth (2Y CAGR)+23.41%

    Valuation Ratios

    Sales and book value multiples are 0.3x and 0.2x.

    P/S Ratio0.3x
    Forward P/S0.3x
    P/B Ratio0.2x
    P/TBV Ratio0.4x

    Price Statistics

    The stock is down 78.24% over 52 weeks and trades 29.22% below its 50-day average.

    Beta (1Y)1.37
    52-Week Change-78.24%
    1-Month Change-22.44%
    3-Month Change-51.35%
    6-Month Change-54.89%
    5-Year Change-97.54%
    Total Return (1Y)-78.24%
    Total Return (3Y CAGR)-49.54%
    Total Return (5Y CAGR)-53.60%
    Return vs SPY (1Y)-88.74%
    Max Drawdown (1Y)-83.21%
    Max Drawdown (3Y)-91.79%
    Sharpe Ratio (1Y)-1.92
    Correlation with SPY (1Y)0.24
    50-Day Average$3.32
    200-Day Average$5.12
    52-Week Range$2.33 to $15.70
    RSI (14 Days)29.2
    Average Volume (20 Days)4.96M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.88x current liabilities, and total debt is 0.12x shareholder equity.

    Current Ratio1.88x
    Quick Ratio1.11x
    Debt / Equity0.12x
    Interest Coverage-3.80x

    Returns and Efficiency

    Return on invested capital is -4.89% over the last 12 months, against a 5-year average of -34.29%.

    Return on Equity (ROE)-10.12%
    Return on Assets (ROA)-7.05%
    Return on Invested Capital (ROIC)-4.89%
    Return on Capital Employed (ROCE)-4.70%
    ROE (5Y Average)-43.62%
    ROA (5Y Average)-31.79%
    ROIC (5Y Average)-34.29%
    Asset Turnover0.44x
    Inventory Turnover2.19x
    Receivables Turnover5.07x
    Cash Conversion Cycle66 days

    Scores

    TLRY has an Altman Z-Score of -2.27, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-2.27
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $963.10M over the last 12 months is up 15.93% from the 12 months before.

    Revenue$963.10M
    Revenue Growth (YoY)+15.93%
    Gross Profit$274.29M
    Operating Income-$77.21M
    Pretax Income-$125.59M
    Net Income-$164.22M
    EBITDA-$18.52M
    EBIT-$89.20M
    Reported EPS (TTM)-$0.75

    Trailing 12 months through Aug 31, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 69.53% of the $2.33B in total assets.

    Cash and Equivalents$214.96M
    Total Debt$201.41M
    Net Cash$13.54M
    Net Cash Per Share$0.10
    Working Capital$376.90M
    Shareholder Equity$1.62B
    Book Value Per Share$12.17
    Tangible Book Value$828.54M
    Tangible Book Per Share$6.21
    Total Assets$2.33B
    Total Liabilities$721.28M

    Balance sheet as of Aug 31, 2026.

    Full balance sheet

    Cash Flow

    After $34.51M of capital spending, operating cash flow left -$119.00M of free cash flow.

    Operating Cash Flow-$84.49M
    Capital Expenditures$34.51M
    Free Cash Flow-$119.00M
    FCF Per Share-$0.81
    Depreciation and Amortization$70.68M

    Trailing 12 months through Aug 31, 2026.

    Full cash flow statement

    Margins

    The operating margin is -8.02%.

    Gross Margin28.48%
    Operating Margin-8.02%
    Pretax Margin-13.04%
    Net Margin-17.05%
    EBITDA Margin-1.92%
    EBIT Margin-9.26%
    FCF Margin-12.36%
    Gross Margin (5Y Average)25.62%

    Growth

    Revenue grew 13.44% a year over 3 years.

    Revenue Growth (3Y CAGR)+13.44%
    Revenue Growth (5Y CAGR)+12.28%
    Book Value Per Share Growth (2Y CAGR)-41.54%
    Tangible Book Per Share Growth (2Y CAGR)+7.30%

    Revenue and profit by year

    Dividends and Yields

    TLRY does not pay a dividend. Its free cash flow yield is -37.98%.

    FCF Yield-37.98%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-10 reverse split on Dec 2, 2025.

    Last Split DateDec 2, 2025
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 8 similar companies, TLRY has the lowest P/S.

    P/S Ratio0.3x vs 1.9x median
    ROIC-4.89% vs -16.60% median
    Revenue Growth (Trailing 4 Quarters, YoY)+15.93% vs +13.87% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 12.47% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+12.47%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About TLRY

    What is TLRY's market cap?

    Tilray has a market cap of $345.82M. Its enterprise value, which adds debt and subtracts cash, is $332.28M.

    How many shares of TLRY are outstanding?

    Tilray has 133.34M shares outstanding. The count is up 25.76% from a year earlier.

    Does TLRY pay a dividend?

    No. Tilray does not pay a dividend.

    How much debt does TLRY have?

    Tilray has $201.41M of total debt and $214.96M of cash and equivalents, a net cash position of $13.54M.